                         SEQUENCE LISTING

<110>  CASE WESTERN RESERVE UNIVERSITY
       Lavik, Erin
 
<120>  NEUTRALLY CHARGED SYNTHETIC PLATELETS TO MITIGATE COMPLEMENT 
       RESPONSE

<130>  31973/47879A PCT

<150>  US-61/812,642
<151>  2013-04-16

<150>  US-61/864,969
<151>  2013-08-12

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Arg Gly Asp Ser 
1               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Gly Arg Gly Asp Ser 
1               5   


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Gly Arg Gly Asp Ser Pro 
1               5       


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Gly Arg Gly Asp Ser Pro Lys 
1               5           


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Gly Arg Gly Asp Asn 
1               5   


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Gly Arg Gly Asp Asn Pro 
1               5       


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Gly Gly Gly Gly Arg Gly Asp Ser 
1               5               


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Gly Arg Gly Asp Lys 
1               5   


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Gly Arg Gly Asp Thr Pro 
1               5       


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Tyr Arg Gly Asp Ser 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PLGA-PLL-PEG

<400>  11

Gly Arg Gly Asp Ser 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG 4600

<400>  12

Gly Arg Gly Asp Ser 
1               5   


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

His His Leu Gly Gly Ala Lys Gln Ala Gly Asp Val 
1               5                   10          


